(SGTX) –
-
Form SC 13G/A Sigilon Therapeutics, Filed by: Flagship Ventures Fund V, L.P.
-
Form 15-12G Sigilon Therapeutics,
-
Form EFFECT Sigilon Therapeutics,
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: Flagship Pioneering Special Opportunities Fund II, L.P.
-
Form SC 13D/A Sigilon Therapeutics, Filed by: ELI LILLY & Co
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: ELI LILLY & Co
-
Eli Lilly & Co. (LLY) completes takeover of Sigilon Therapeutics (SGTX)
-
Lilly Completes Acquisition of Sigilon Therapeutics
-
Form S-8 POS Sigilon Therapeutics,
-
Form S-8 POS Sigilon Therapeutics,
-
Form S-8 POS Sigilon Therapeutics,
-
Form S-8 POS Sigilon Therapeutics,
-
Form POS AM Sigilon Therapeutics,
-
Form 8-K Sigilon Therapeutics, For: Aug 11
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: RUFFOLO ROBERT R
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: Ashton-Rickardt Philip
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: Shaff Eric D.
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: Cox John
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: Kowalsky Matthew Paul
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: Patel Kavita
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: Cole Douglas G.
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: Oesterle Stephen N.
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: Yuan Qing Sarah
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: Pontes Josias
-
Form 4 Sigilon Therapeutics, For: Aug 11 Filed by: Vivaldi Coelho Rogerio
-
Form 25-NSE Sigilon Therapeutics, Filed by: Nasdaq Stock Market LLC
-
Form SC TO-T/A Sigilon Therapeutics, Filed by: ELI LILLY & Co
-
Form SC 14D9/A Sigilon Therapeutics, Filed by: Sigilon Therapeutics, Inc.
-
Form 10-Q Sigilon Therapeutics, For: Jun 30
-
Form SC TO-T/A Sigilon Therapeutics, Filed by: ELI LILLY & Co
-
Form SC 14D9/A Sigilon Therapeutics, Filed by: Sigilon Therapeutics, Inc.
-
Form 4 Sigilon Therapeutics, For: Jul 27 Filed by: Yuan Qing Sarah
-
Form 4 Sigilon Therapeutics, For: Jul 21 Filed by: Pontes Josias
-
Form 4 Sigilon Therapeutics, For: Jul 21 Filed by: Vivaldi Coelho Rogerio
-
Form SC TO-T/A Sigilon Therapeutics, Filed by: ELI LILLY & Co
-
Form SC 14D9/A Sigilon Therapeutics, Filed by: Sigilon Therapeutics, Inc.
-
Form SC 14D9 Sigilon Therapeutics, Filed by: Sigilon Therapeutics, Inc.
-
Form SC TO-T Sigilon Therapeutics, Filed by: ELI LILLY & Co
-
Form SC 13D Sigilon Therapeutics, Filed by: ELI LILLY & Co
-
Form 3 Sigilon Therapeutics, For: Jun 28 Filed by: ELI LILLY & Co
-
Sigilon Therapeutics (SGTX) PT Raised to $21 at Morgan Stanley
-
BTIG Downgrades Sigilon Therapeutics (SGTX) to Neutral
-
Form 8-K Sigilon Therapeutics, For: Jun 28
-
Form SC TO-C Sigilon Therapeutics, Filed by: ELI LILLY & Co
-
Eli Lilly & Co. (LLY) to Acquire Sigilon Therapeutics (SGTX) for $14.92/sh plus CVR
-
Lilly to Acquire Sigilon Therapeutics
-
Sigilon Therapeutics (SGTX) PT Lowered to $7 at Morgan Stanley
-
Form 8-K Sigilon Therapeutics, For: May 19
-
Form 4 Sigilon Therapeutics, For: May 19 Filed by: Shaff Eric D.
-
Form 4 Sigilon Therapeutics, For: May 19 Filed by: Oesterle Stephen N.
Back to SGTX Stock Lookup